tranexamic acid has been researched along with Uterine Diseases in 3 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Uterine Diseases: Pathological processes involving any part of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid is an antifibrinolytic agent that has shown to effectively reduce bleeding complications within other surgical and medical areas." | 2.82 | Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. ( Bergholt, T; Moeller, C; Ottesen, B; Ravn, P; Schouenborg, L; Settnes, A; Topsoee, MF, 2016) |
| "Dysfunctional uterine bleeding is defined as heavy menstrual uterine bleeding not due to any recognisable cause and is therefore a diagnosis of exclusion." | 2.42 | Dysfunctional uterine bleeding. ( Farrell, E, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topsoee, MF | 1 |
| Bergholt, T | 1 |
| Ravn, P | 1 |
| Schouenborg, L | 1 |
| Moeller, C | 1 |
| Ottesen, B | 1 |
| Settnes, A | 1 |
| Farrell, E | 1 |
| Svanberg, L | 1 |
| Astedt, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815] | Phase 4 | 200 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
| Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245] | Phase 4 | 100 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Uterine Diseases
| Article | Year |
|---|---|
Dysfunctional uterine bleeding.
Topics: Antifibrinolytic Agents; Diagnosis, Differential; Female; Gynecologic Surgical Procedures; Humans; I | 2004 |
1 trial available for tranexamic acid and Uterine Diseases
| Article | Year |
|---|---|
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; | 2016 |
1 other study available for tranexamic acid and Uterine Diseases
| Article | Year |
|---|---|
Release of plasminogen activator from normal and neoplastic endometrium.
Topics: Endometrium; Female; Humans; Hyperplasia; Plasminogen Activators; Tranexamic Acid; Uterine Diseases; | 1979 |